Innovative Drug Development for Headache Disorders

Innovative Drug Development for Headache Disorders

Jes Olesen and Nabih Ramadan

Print publication date: Aug 2008

ISBN: 9780199552764

Publisher: Oxford University Press

Abstract

This resource summarizes the several promising new avenues for the development of future drugs for the treatment of migraine, including cortical-spreading depression inhibition, nitric oxide synthase inhibition and calcitonin gene-related peptide (CGRP) receptor antagonism, as well as other potential targets, and presents frontline knowledge of these evolving modalities as far as it is available in the public domain.

Table of Contents